International phase III trials in epithelial ovarian cancer (EOC)

被引：0
|
作者：
McGuire, William P.
机构：
[1] Georgetown Univ, Lombardi Canc Inst, Washington, DC USA
[2] Franklin Sq Hosp Ctr, Weinberg Canc Inst, Baltimore, MD USA
来源：
CANCER INVESTIGATION | 2007年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [1] Adjuvant chemotherapy for epithelial ovarian cancer (EOC)
    Kumar, Lalit
    Prasad, Roopa Hari
    Sengar, Manju
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2006, 27 (01) : 4 - 5
  • [2] Autotaxin (ATX) isoforms in epithelial ovarian cancer (EOC).
    Shankar, S
    Kung, A
    Fishman, DA
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 410A - 410A
  • [3] Peritoneal inflammation - A microenvironment for epithelial ovarian cancer (EOC)
    Freedman R.S.
    Deavers M.
    Liu J.
    Wang E.
    [J]. Journal of Translational Medicine, 2 (1)
  • [4] Role of autotaxin (ATX) in epithelial ovarian cancer (EOC).
    Shankar, S
    Clair, T
    Stracke, M
    Auersperg, N
    Fishman, DA
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 409A - 409A
  • [5] Early Stage Epithelial Ovarian Cancer (EOC): AIIMS Experience
    Hariprasad, Roopa
    Kumar, S.
    Bhatla, N.
    Thulkar, S.
    Dawar, R.
    Vijayraghwan, M.
    Kumar, Lalit
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2009, 30 (05) : 13 - 13
  • [6] IMPACT OF TIME OF SURGERY IN OPTIMALLY DEBULKED STAGE III&IV EPITHELIAL OVARIAN CANCER(EOC)
    Barretina-Ginesta, M. P.
    Ahmed-Ouahid, H.
    Sala, E.
    Lindo, D.
    Buxo, M.
    Sala-Gonzalez, N.
    Florensa, A.
    Taltavull, A.
    Brunet-Vidal, J.
    Alvarez-Castano, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 404 - 405
  • [7] The role of factor (f) XIII in patients with advanced epithelial ovarian cancer (EOC) FIGO III/IV
    Yazdian, M.
    Ataseven, B.
    Schneider, S.
    Baert, T.
    Bommert, M.
    Traut, A.
    du Bois, A.
    Harter, P.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E212 - E212
  • [8] Characterization of breast cancer resistance protein (BCRP) in epithelial ovarian cancer (EOC)
    Sayer, R
    Turner, J
    Sullivan, D
    Fiorica, J
    Lancaster, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 140S - 140S
  • [9] Phase II study of letrozole in estrogen receptor (ER) positive relapsed epithelial ovarian cancer (EOC).
    Gourlev, C.
    Smyth, J. F.
    Mackean, M.
    Stevenson, A.
    Williams, A.
    Rye, T.
    Reed, N.
    Vasey, P.
    Gabra, H.
    Langdon, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 261S - 261S
  • [10] Intraperitoneal chemotherapy (IPC) in older women with epithelial ovarian cancer (EOC)
    Tew, W. P.
    O'Cearbhaill, R.
    Zhou, Q.
    Thaler, H.
    Konner, J.
    Hensley, M. L.
    Sabbatini, P.
    Spriggs, D.
    Aghajanian, C.
    Lichtman, S. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345